80 related articles for article (PubMed ID: 29374971)
1. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
Li Z; Zhang Y; Zhang K; Wu Z; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-modified chitosan-capped mesoporous silica nanoparticles for co-delivery of cytarabine and daunorubicin in leukemia.
Heydari SR; Ghahremani MH; Atyabi F; Bafkary R; Jaafari MR; Dinarvand R
Int J Pharm; 2023 Nov; 646():123495. PubMed ID: 37806507
[TBL] [Abstract][Full Text] [Related]
4. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
Varshosaz J; Dayani L; Chegini SP; Minaiyan M
IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
[TBL] [Abstract][Full Text] [Related]
5. Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.
Dizaj SM; Kouhsoltani M; Pourreza K; Sharifi S; Abdolahinia ED
Pharm Nanotechnol; 2024; 12(3):269-275. PubMed ID: 37594097
[TBL] [Abstract][Full Text] [Related]
6. Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles.
Du G; Woythe L; van der Maaden K; Leone M; Romeijn S; Kros A; Kersten G; Jiskoot W; Bouwstra JA
Pharm Res; 2018 Aug; 35(10):189. PubMed ID: 30105542
[TBL] [Abstract][Full Text] [Related]
7. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin Loaded Amino-Functionalized MCM-48 Mesoporous Silica Nanoparticles as a Promising Drug Carrier in Bone Substitutes for Bacterial Infection Management.
Rahaman SN; Pathmanapan S; Sidharthan A; Anandasadagopan SK
Appl Biochem Biotechnol; 2023 Nov; 195(11):6607-6632. PubMed ID: 36892681
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
[TBL] [Abstract][Full Text] [Related]
10. Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy.
He L; Habibovic P; van Rijt S
Biomater Sci; 2023 May; 11(11):3828-3839. PubMed ID: 37074160
[TBL] [Abstract][Full Text] [Related]
11. Injectable Multicomponent Biomimetic Gel Composed of Inter-Crosslinked Dendrimeric and Mesoporous Silica Nanoparticles Exhibits Highly Tunable Elasticity and Dual Drug Release Capacity.
Wang J; Li B; Pu X; Wang X; Cooper RC; Gui Q; Yang H
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10202-10210. PubMed ID: 32023033
[TBL] [Abstract][Full Text] [Related]
12. Fluorescein isothiocyanate-dyed mesoporous silica nanoparticles for tracking antioxidant delivery.
Rashidi L; Ganji F; Vasheghani-Farahani E
IET Nanobiotechnol; 2017 Jun; 11(4):454-462. PubMed ID: 28530196
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer.
Bellapu KK; Joga R; Kannan BR; Yerram S; Varpe P; Mergu T; Vasu PY; Srivastava S; Kumar S
Pharm Pat Anal; 2023 Nov; 12(6):261-273. PubMed ID: 38214201
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies.
Budiman A; Anastasya G; Handini AL; Lestari IN; Subra L; Aulifa DL
Int J Nanomedicine; 2024; 19():2199-2225. PubMed ID: 38465205
[TBL] [Abstract][Full Text] [Related]
15. Preparation of mesoporous silica/hydroxyapatite loaded quercetin nanoparticles and research on its antibacterial properties.
Yi X; Bao F; Fu S; Yang Y; Xu Y
Med Eng Phys; 2024 Apr; 126():104160. PubMed ID: 38621842
[TBL] [Abstract][Full Text] [Related]
16. Tin-loaded mesoporous silica nanoparticles: Antineoplastic properties and genotoxicity assessment.
Choudante PC; Nethi SK; Díaz-García D; Prashar S; Misra S; Gómez-Ruiz S; Patra CR
Biomater Adv; 2022 Jun; 137():212819. PubMed ID: 35929256
[TBL] [Abstract][Full Text] [Related]
17. Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect.
Yin S; Cai L; Li X; Lin K; Shi X; Zhang H; Wang L; Li J
Eur J Pharm Sci; 2024 Apr; 195():106719. PubMed ID: 38309442
[TBL] [Abstract][Full Text] [Related]
18. Preparation, Characterization, and Evaluation of Mesoporous Silica Nanoparticles in Enhancing Oral Bioavailability of Poorly Water-Soluble Drugs.
Zhang H; Zuo F; Wang B; Qiu X
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38310438
[TBL] [Abstract][Full Text] [Related]
19. Quaternized chitosan-based organic-inorganic nanohybrid nanoparticles loaded with prothioconazole for efficient management of fungal diseases with minimal environmental impact.
Niu J; Wang C; Qiao K; Liao M; Liu Y; Ding Y; Yao H; Zhang H; Cao H
Int J Biol Macromol; 2024 Mar; 262(Pt 2):129662. PubMed ID: 38266842
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica-based nanocarriers with dual response to pH and ROS for enhanced anti-inflammation therapy of 5-demethylnobiletin against psoriasis-like lesions.
Wang Y; Zhang Y; Yang Z; Zhang L; Chen X; Yang G; Zhan J; Li S; He F; Fan G
Int J Pharm; 2023 Oct; 645():123373. PubMed ID: 37673281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
